Targeted binding agents directed to PDGFR-alpha and uses thereof

Details for Australian Patent Application No. 2012202865 (hide)

Owner AstraZeneca AB

Inventors Laing, Naomi; Kang, Jaspal Singh; Foltz, Ian; Gazit-Bornstein, Gadi; Yang, Xiao-Dang; Cartlidge, Susan Ann; Blakey, David Charles; Taylor, Laura

Agent Davies Collison Cave

Pub. Number AU-A-2012202865

Parent 2007348940

Filing date 16 May 2012

Wipo publication date 7 June 2012

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

Event Publications

31 May 2012 Complete Application Filed

7 June 2012 Application Open to Public Inspection

  Published as AU-A-2012202865

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012202866-Conjugation product

2012202864-System for trapping flying insects with attractant lures